Immune checkpoint inhibition in COVID-19: risks and benefits.

Immune checkpoint inhibition (ICI) is a novel cancer immunotherapy, which is administered in patients with metastatic, refractory, or relapsed solid cancer types. Since the initiation of the Corona...